Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
60 results (top 60)
- 4상모집 예정· Acute Coronary Syndromes (ACS)급성 관상동맥 증후군에서 인클리시란을 이용한 조기 강화 지질 저하 치료
Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
협력: 한미약품, 노바티스
- 3상모집 예정· Hypertension본태성 고혈압 환자에서 HCP1803-4의 효능 및 안전성 평가
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
리드: 한미약품
- 2상모집 중· Primary Brain TumorBRAF 변이 고형암 환자에서 벨바라페닙의 중추신경계 효과 평가
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
- 2상모집 중· Type 2 Diabetes Mellitus제2형 당뇨병 대상자에서 HM15275 평가 연구
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
- 3상모집 중· Type 2 Diabetes메트포르민 및 다파글리플로진으로 조절이 부족한 2형 당뇨병에서 HM11260C의 효능 및 안전성 평가
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
리드: 한미약품
- 단계 미표기모집 중· Hypertension한국 고혈압 환자에서 순차적 삼중 복합 요법(암로디핀/로사르탄/클로르탈리돈)의 효과성 및 안전성
Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
리드: 한미약품
- 해당없음모집 중· Dyslipidemia Associated With Type II Diabetes MellitusModerate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
협력: 한미약품, 유한양행
- 2상모집 중· Advanced or Metastatic MelanomaBelvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
- 2상모집 중단 (진행 중)· ObeseStudy to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
- 1/2상모집 중· Fabry DisesaseA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
리드: GC녹십자 · 협력: 한미약품
- 4상모집 중· Coronary Artery DiseaseComparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
협력: 한미약품, 유한양행
- 1상모집 중· Advanced or Metastatic Solid TumorsDose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
- 3상완료· Chronic Low-back PainA Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
리드: 한미약품
- 해당없음모집 중· Ischemic StrokeOptimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
협력: 한미약품
- 3상완료· HypertensionA Study to Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension Patients
리드: 한미약품
- 1상모집 중· Advanced or Metastatic Solid TumorsDose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
- 4상상태 미확인· Breast NeoplasmsReducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
협력: 한미약품
- 1상완료· Healthy VolunteersA Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
리드: 한미약품
- 4상모집 중· Coronary Artery DiseaseHarmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
- 3상완료· Gastric UlcerA Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
리드: 한미약품
- 1상모집 중단 (진행 중)· Advanced or Metastatic Solid TumorsDose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
리드: 한미약품
- 3상완료· HypertensionA Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
리드: 한미약품
- 2상모집 중단 (진행 중)· Congenital HyperinsulinismHM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
리드: 한미약품
- 2상모집 중· Short Bowel SyndromePhase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
리드: 한미약품
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
리드: 한미약품
- 2상완료· Gastric CancerFLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
리드: 한미약품
- 1상완료· Healthy Adult VolunteerStudy to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
리드: 한미약품
- 2상완료· HypertensionA Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
리드: 한미약품
- 1상완료· Atrial FibrillationThe Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
리드: 한미약품
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
리드: 한미약품
- 2상완료· NASH - Nonalcoholic SteatohepatitisStudy to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
리드: 한미약품
- 3상완료· Primary HypercholesterolemiaEfficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
리드: 한미약품
- 1상완료· Healthy VolunteerFood-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
리드: 한미약품
- 1상완료· Obese With ComorbiditiesStudy for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
리드: 한미약품
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.